Literature DB >> 17021263

ACE2: a new target for prevention of diabetic nephropathy?

Julie R Ingelfinger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17021263     DOI: 10.1681/ASN.2006090986

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  11 in total

Review 1.  ACE and ACE2 in kidney disease.

Authors:  Sonoo Mizuiri; Yasushi Ohashi
Journal:  World J Nephrol       Date:  2015-02-06

2.  Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro.

Authors:  Philipp K Haber; Minghao Ye; Jan Wysocki; Christoph Maier; Syed K Haque; Daniel Batlle
Journal:  Hypertension       Date:  2014-01-20       Impact factor: 10.190

3.  What Is the Role of Angiotensin-Converting Enzyme 2 (ACE2) in COVID-19 Infection in Hypertensive Patients With Diabetes?

Authors:  Thadathilankal-Jess John; Kiran John
Journal:  Can J Cardiol       Date:  2020-04-08       Impact factor: 5.223

4.  Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy.

Authors:  G Wang; F M-M Lai; K-B Lai; K-M Chow; C-H B Kwan; K-T P Li; C-C Szeto
Journal:  Diabetologia       Date:  2008-04-04       Impact factor: 10.122

5.  Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.

Authors:  Jan Wysocki; Minghao Ye; Eva Rodriguez; Francisco R González-Pacheco; Clara Barrios; Karla Evora; Manfred Schuster; Hans Loibner; K Bridget Brosnihan; Carlos M Ferrario; Josef M Penninger; Daniel Batlle
Journal:  Hypertension       Date:  2009-11-30       Impact factor: 10.190

6.  Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression.

Authors:  J-C Zhong; X-Y Yu; Q-X Lin; X-H Li; X-Z Huang; D-Z Xiao; S-G Lin
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

7.  Investigation of angiotensin-1 converting enzyme 2 gene (G8790A) polymorphism in patients of type 2 diabetes mellitus with diabetic nephropathy in Pakistani population.

Authors:  Hooria Younas; Tahira Ijaz; Nakhshab Choudhry
Journal:  PLoS One       Date:  2022-02-17       Impact factor: 3.240

8.  Platelets and renal failure in the SARS-CoV-2 syndrome.

Authors:  Muhanad Taha; Dahlia Sano; Samer Hanoudi; Zahia Esber; Morvarid Elahi; Ali Gabali; Teena Chopra; Sorin Draghici; Lobelia Samavati
Journal:  Platelets       Date:  2020-09-06       Impact factor: 3.862

Review 9.  [Angiotensin converting enzyme 2 and its emerging role in the regulation of the renin angiotensin system].

Authors:  María José Soler; Josep Lloveras; Daniel Batlle
Journal:  Med Clin (Barc)       Date:  2008-07-12       Impact factor: 1.725

10.  A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.

Authors:  Sajjan Rajpoot; Tomokazu Ohishi; Ashutosh Kumar; Qiuwei Pan; Sreeparna Banerjee; Kam Y J Zhang; Mirza S Baig
Journal:  Drugs R D       Date:  2021-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.